Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds

Our latest crop of biofinancings features a nine-figure round for #Ambrosia, with #PinnacleMedicines, #Immutrin, and #GilgameshPharma also raising new funds.

Rumour partly confirmed as AbbVie acquires Gilgamesh drug Reports of AbbVie's interest in Gilgamesh Pharma were true, as the companies have agreed a $1.2bn acquisition deal for a psychedelic depression drug.

Less than a month after reports of takeover talks between #AbbVie and #GilgameshPharma first emerged, the pair have gone public with details of a $1.2 billion #deal – but it is not an acquisition. #psychedelics #depression

pharmaphorum.com/news/rumour-...